The ErbB4 Ligand Neuregulin-4 Protects against Experimental Necrotizing Enterocolitis

American Journal of Pathology

Volumn 184, Issue 10, 2014, Pages 2768-2778

  McElroy, Steven J ^a   Castle, Shannon L ^b   Bernard, Jessica K ^b   Almohazey, Dana ^b   Hunter, Catherine J ^c   Bell, Brandon A ^b   Alam, Denise Al ^b   Wang, Larry ^b   Ford, Henri R ^b   Freyz, Mark R ^b  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGENTS USED IN INFLAMMATORY BOWEL DISEASE; APOPTOSIS INHIBITOR; CYTOKINE; DITHIZONE; EPIDERMAL GROWTH FACTOR RECEPTOR 4; NEU DIFFERENTIATION FACTOR; NEUREGULIN 4; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR; UNCLASSIFIED DRUG; ERBB4 PROTEIN, HUMAN; ERBB4 PROTEIN, MOUSE; ERBB4 PROTEIN, RAT; NEUREGULIN-4;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ARTIFICIAL MILK; BREAST MILK; CELL LOSS; CONTROLLED STUDY; CRONOBACTER MUYTJENSII; CYTOKINE PRODUCTION; DISEASE SEVERITY; HUMAN; IN VITRO STUDY; INCIDENCE; INTESTINE EPITHELIUM CELL; INTESTINE INJURY; KLEBSIELLA PNEUMONIAE INFECTION; NECROTIZING ENTEROCOLITIS; NEWBORN; NEWBORN HYPOXIA; NONHUMAN; PANETH CELL; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RAT; SIGNAL TRANSDUCTION; YOUNG ADULT; ANIMAL; CHEMISTRY; DISEASE MODEL; ENTEROCOLITIS, NECROTIZING; EPITHELIUM CELL; FEMALE; ILEUM; INTESTINE; METABOLISM; MOUSE; PATHOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; ANIMALS, NEWBORN; CYTOKINES; DISEASE MODELS, ANIMAL; ENTEROCOLITIS, NECROTIZING; EPITHELIAL CELLS; FEMALE; HUMANS; ILEUM; INTESTINES; MICE; MILK, HUMAN; NEUREGULINS; PANETH CELLS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ERBB-4; SIGNAL TRANSDUCTION;

EID: 84922454995     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2014.06.015     Document Type: Article

References (58)

1. Hunter CJ, Upperman JS, Ford HR, Camerini V: Understanding the susceptibility of the premature infant to necrotizing enterocolitis (NEC). Pediatr Res 2008, 63:117-123.
2. Emami CN, Petrosyan M, Giuliani S, Williams M, Hunter C, Prasadarao NV, Ford HR: Role of the host defense system and intestinal microbial flora in the pathogenesis of necrotizing enterocolitis. Surg Infect (Larchmt) 2009, 10:407-417.
3. McElroy SJ, Underwood MA, Sherman MP: Paneth cells and necrotizing enterocolitis: A novel hypothesis for disease pathogenesis. Neonatology 2013, 103:10-20.
4. Hunter CJ, Petrosyan M, Ford HR, Prasadarao NV: Enterobacter sakazakii: An emerging pathogen in infants and neonates. Surg Infect (Larchmt) 2008, 9:533-539.
5. Hunter CJ, Singamsetty VK, Chokshi NK, Boyle P, Camerini V, Grishin AV, Upperman JS, Ford HR, Prasadarao NV: Enterobacter sakazakii enhances epithelial cell injury by inducing apoptosis in a rat model of necrotizing enterocolitis. J Infect Dis 2008, 198:586-593.
6. Caplan MS, Hsueh W: Necrotizing enterocolitis: role of platelet activating factor, endotoxin, and tumor necrosis factor. J Pediatr 1990, 117:S47-S51.
7. Halpern MD, Clark JA, Saunders TA, Doelle SM, Hosseini DM, Stagner AM, Dvorak B: Reduction of experimental necrotizing enterocolitis with anti-TNF-alpha. Am J Physiol Gastrointest Liver Physiol 2006, 290:G757-G764.
8. Seitz G, Warmann SW, Guglielmetti A, Heitmann H, Ruck P, Kreis ME, Fuchs J: Protective effect of tumor necrosis factor alpha antibody on experimental necrotizing enterocolitis in the rat. J Pediatr Surg 2005, 40:1440-1445.
9. Blakely ML, Lally KP, McDonald S, Brown RL, Barnhart DC, Ricketts RR, Thompson WR, Scherer LR, Klein MD, Letton RW, Chwals WJ, Touloukian RJ, Kurkchubasche AG, Skinner MA, Moss RL, Hilfiker ML; Network NECSotNNR: Postoperative outcomes of extremely low birth-weight infants with necrotizing enterocolitis or isolated intestinal perforation: A prospective cohort study by the NICHD Neonatal Research Network. Ann Surg 2005, 241:984-989. discussion 9-94.
10. Fitzgibbons SC, Ching Y, Yu D, Carpenter J, Kenny M, Weldon C, Lillehei C, Valim C, Horbar JD, Jaksic T: Mortality of necrotizing enterocolitis expressed by birth weight categories. J Pediatr Surg 2009, 44:1072-1075. discussion 5-6.
11. Rowe MI, Reblock KK, Kurkchubasche AG, Healey PJ: Necrotizing enterocolitis in the extremely low birth weight infant. J Pediatr Surg 1994, 29:987-990. discussion 90-91.
12. Lucas A, Cole TJ: Breast milk and neonatal necrotising enterocolitis. Lancet 1990, 336:1519-1523.
13. Schanler RJ, Shulman RJ, Lau C: Feeding strategies for premature infants: Beneficial outcomes of feeding fortified human milk versus preterm formula. Pediatrics 1999, 103:1150-1157.
14. Warner BW: NEC, EGF, milk, and spit. Gastroenterology 2002, 123: 383-384. discussion 4.
15. Michalsky MP, Lara-Marquez M, Chun L, Besner GE: Heparinbinding EGF-like growth factor is present in human amniotic fluid and breast milk. J Pediatr Surg 2002, 37:1-6.
16. Nair RR, Warner BB, Warner BW: Role of epidermal growth factor and other growth factors in the prevention of necrotizing enterocolitis. Semin Perinatol 2008, 32:107-113.
17. Dvorak B, Halpern MD, Holubec H, Williams CS, McWilliam DL, Dominguez JA, Stepankova R, Payne CM, McCuskey RS: Epidermal growth factor reduces the development of necrotizing enterocolitis in a neonatal rat model. Am J Physiol Gastrointest Liver Physiol 2002, 282:G156-G164.
18. Feng J, El-Assal ON, Besner GE: Heparin-binding epidermal growth factor-like growth factor reduces intestinal apoptosis in neonatal rats with necrotizing enterocolitis. J Pediatr Surg 2006, 41:742-747. discussion -7.
19. Carpenter G: ErbB-4: Mechanism of action and biology. Exp Cell Res 2003, 284:66-77.
20. Kaushansky A, Gordus A, Budnik BA, Lane WS, Rush J, MacBeath G: System-wide investigation of ErbB4 reveals 19 sites of Tyr phosphorylation that are unusually selective in their recruitment properties. Chem Biol 2008, 15:808-817.
21. Harari D, Tzahar E, Romano J, Shelly M, Pierce JH, Andrews GC, Yarden Y: Neuregulin-4: A novel growth factor that acts through the ErbB-4 receptor tyrosine kinase. Oncogene 1999, 18:2681-2689.
22. Bernard JK, McCann SP, Bhardwaj V, Washington MK, Frey MR: Neuregulin-4 is a survival factor for colon epithelial cells both in culture and in vivo. J Biol Chem 2012, 287:39850-39858.
23. Frey MR, Edelblum KL, Mullane MT, Liang D, Polk DB: The ErbB4 growth factor receptor is required for colon epithelial cell survival in the presence of TNF. Gastroenterology 2009, 136:217-226.
24. Hilliard VC, Frey MR, Dempsey PJ, Peek RM Jr, Polk DB: TNFalpha converting enzyme-mediated ErbB4 transactivation by TNF promotes colonic epithelial cell survival. Am J Physiol Gastrointest Liver Physiol 2011, 301:G338-G346.
25. Committee for the Update of the Guide for the Care and Use of Laboratory Animals; National Research Council: Guide for the Care and Use of Laboratory Animals: Eighth Edition. Washington, DC, National Academies Press, 2011.
26. Nadler EP, Dickinson E, Knisely A, Zhang XR, Boyle P, Beer- Stolz D, Watkins SC, Ford HR: Expression of inducible nitric oxide synthase and interleukin-12 in experimental necrotizing enterocolitis. J Surg Res 2000, 92:71-77.
27. Zhang C, ShermanMP, Prince LS, Bader D, Weitkamp JH, Slaughter JC, McElroy SJ: Paneth cell ablation in the presence of Klebsiella pneumoniae induces necrotizing enterocolitis (NEC)-like injury in the small intestine of immature mice. Dis Model Mech 2012, 5:522-532.
28. Sawada M, Takahashi K, Sawada S, Midorikawa O: Selective killing of Paneth cells by intravenous administration of dithizone in rats. Int J Exp Pathol 1991, 72:407-421.
29. Long W, Wagner KU, Lloyd KC, Binart N, Shillingford JM, Hennighausen L, Jones FE: Impaired differentiation and lactational failure of Erbb4-deficient mammary glands identify ERBB4 as an obligate mediator of STAT5. Development 2003, 130:5257-5268.
30. Sato T, Stange DE, Ferrante M, Vries RG, Van Es JH, Van den Brink S, Van Houdt WJ, Pronk A, VanGorp J, Siersema PD, Clevers H: Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett's epithelium. Gastroenterology 2011, 141:1762-1772.
31. Iversen C, Mullane N, McCardell B, Tall BD, Lehner A, Fanning S, Stephan R, Joosten H: Cronobacter gen. nov., a new genus to accommodate the biogroups of Enterobacter sakazakii, and proposal of Cronobacter sakazakii gen. nov., comb. nov., Cronobacter malonaticus sp. nov., Cronobacter turicensis sp. nov., Cronobacter muytjensii sp. nov., Cronobacter dublinensis sp. nov., Cronobacter genomospecies 1, and of three subspecies, Cronobacter dublinensis subsp. dublinensis subsp. nov., Cronobacter dublinensis subsp. lausannensis subsp. nov. and Cronobacter dublinensis subsp. lactaridi subsp. nov. Int J Syst Evol Microbiol 2008, 58:1442-1447.
32. Sato T, Vries RG, Snippert HJ, van de Wetering M, Barker N, Stange DE, van Es JH, Abo A, Kujala P, Peters PJ, Clevers H: Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature 2009, 459:262-265.
33. Yan F, Cao H, Cover TL, Washington MK, Shi Y, Liu L, Chaturvedi R, Peek RM Jr, Wilson KT, Polk DB: Colon-specific delivery of a probiotic-derived soluble protein ameliorates intestinal inflammation in mice through an EGFR-dependent mechanism. J Clin Invest 2011, 121:2242-2253.
34. Zhang Y, Dube PE, Washington MK, Yan F, Polk DB: ErbB2 and ErbB3 regulate recovery from dextran sulfate sodium-induced colitis by promoting mouse colon epithelial cell survival. Lab Invest 2012, 92:437-450.
35. Yamaoka T, Yan F, Cao H, Hobbs SS, Dise RS, Tong W, Polk DB: Transactivation of EGF receptor and ErbB2 protects intestinal epithelial cells from TNF-induced apoptosis. Proc Natl Acad Sci U S A 2008, 105:11772-11777.
36. Frey MR, Hilliard VC, Mullane MT, Polk DB: ErbB4 promotes cyclooxygenase-2 expression and cell survival in colon epithelial cells. Lab Invest 2010, 90:1415-1424.
37. Dvorak B, Fituch CC, Williams CS, Hurst NM, Schanler RJ: Increased epidermal growth factor levels in human milk of mothers with extremely premature infants. Pediatr Res 2003, 54:15-19.
38. Srinivasan R, Poulsom R, Hurst HC, Gullick WJ: Expression of the c-erbB-4/HER4 protein and mRNA in normal human fetal and adult tissues and in a survey of nine solid tumour types. J Pathol 1998, 185: 236-245.
39. Feng Y, Teitelbaum DH: Epidermal growth factor/TNF-alpha transactivation modulates epithelial cell proliferation and apoptosis in a mouse model of parenteral nutrition. Am J Physiol Gastrointest Liver Physiol 2012, 302:G236-G249.
40. Read LC, Francis GL, Wallace JC, Ballard FJ: Growth factor concentrations and growth-promoting activity in human milk following premature birth. J Dev Physiol 1985, 7:135-145.
41. Yamaoka T, Frey MR, Dise RS, Bernard JK, Polk DB: Specific epidermal growth factor receptor autophosphorylation sites promote mouse colon epithelial cell chemotaxis and restitution. Am J Physiol Gastrointest Liver Physiol 2011, 301:G368-G376.
42. Lee D, Yu M, Lee E, Kim H, Yang Y, Kim K, Pannicia C, Kurie JM, Threadgill DW: Tumor-specific apoptosis caused by deletion of the ERBB3 pseudo-kinase in mouse intestinal epithelium. J Clin Invest 2009, 119:2702-2713.
43. Clark JA, Lane RH, Maclennan NK, Holubec H, Dvorakova K, Halpern MD, Williams CS, Payne CM, Dvorak B: Epidermal growth factor reduces intestinal apoptosis in an experimental model of necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol 2005, 288:G755-G762.
44. Radulescu A, Zhang HY, Yu X, Olson JK, Darbyshire AK, Chen Y, Besner GE: Heparin-binding epidermal growth factor-like growth factor overexpression in transgenic mice increases resistance to necrotizing enterocolitis. J Pediatr Surg 2010, 45:1933-1939.
45. Feng J, Besner GE: Heparin-binding epidermal growth factor-like growth factor promotes enterocyte migration and proliferation in neonatal rats with necrotizing enterocolitis. J Pediatr Surg 2007, 42: 214-220.
46. McCole DF, Keely SJ, Coffey RJ, Barrett KE: Transactivation of the epidermal growth factor receptor in colonic epithelial cells by carbachol requires extracellular release of transforming growth factoralpha. J Biol Chem 2002, 277:42603-42612.
47. Coutinho HB, da Mota HC, Coutinho VB, Robalinho TI, Furtado AF, Walker E, King G, Mahida YR, Sewell HF, Wakelin D: Absence of lysozyme (muramidase) in the intestinal Paneth cells of newborn infants with necrotising enterocolitis. J Clin Pathol 1998, 51:512-514.
48. Salzman NH, Polin RA, Harris MC, Ruchelli E, Hebra A, Zirin- Butler S, Jawad A, Martin Porter E, Bevins CL: Enteric defensin expression in necrotizing enterocolitis. Pediatr Res 1998, 44:20-26.
49. Mallow EB, Harris A, Salzman N, Russell JP, De Berardinis RJ, Ruchelli E, Bevins CL: Human enteric defensins. gene structure and developmental expression. J Biol Chem 1996, 271:4038-4045.
50. Neu J, Walker WA: Necrotizing enterocolitis. N Engl J Med 2011, 364:255-264.
51. Yee WH, Soraisham AS, Shah VS, Aziz K, Yoon W, Lee SK; Canadian Neonatal Network: Incidence and timing of presentation of necrotizing enterocolitis in preterm infants. Pediatrics 2012, 129: 298-304.
52. Chen CL, Yu X, James IO, Zhang HY, Yang J, Radulescu A, Zhou Y, Besner GE: Heparin-binding EGF-like growth factor protects intestinal stem cells from injury in a rat model of necrotizing enterocolitis. Lab Invest 2012, 92:331-344.
53. Sherman MP, Bennett SH, Hwang FF, Sherman J, Bevins CL: Paneth cells and antibacterial host defense in neonatal small intestine. Infect Immun 2005, 73:6143-6146.
54. Heuberger J, Kosel F, Qi J, Grossmann KS, Rajewsky K, Birchmeier W: Shp2/MAPK signaling controls goblet/paneth cell fate decisions in the intestine. Proc Natl Acad Sci U S A 2014, 111: 3472-3477.
55. Farin HF, Van Es JH, Clevers H: Redundant sources of Wnt regulate intestinal stem cells and promote formation of Paneth cells. Gastroenterology 2012, 143:1518-1529.
56. Komuro A, Nagai M, Navin NE, Sudol M: WW domain-containing protein YAP associates with ErbB-4 and acts as a co-transcriptional activator for the carboxyl-terminal fragment of ErbB-4 that translocates to the nucleus. J Biol Chem 2003, 278:33334-33341.
57. Barry ER, Morikawa T, Butler BL, Shrestha K, de la Rosa R, Yan KS, Fuchs CS, Magness ST, Smits R, Ogino S, Kuo CJ, Camargo FD: Restriction of intestinal stem cell expansion and the regenerative response by YAP. Nature 2013, 493:106-110.
58. Hunter CJ, Williams M, Petrosyan M, Guner Y, Mittal R, Mock D, Upperman JS, Ford HR, Prasadarao NV: Lactobacillus bulgaricus prevents intestinal epithelial cell injury caused by Enterobacter sakazakii-induced nitric oxide both in vitro and in the newborn rat model of necrotizing enterocolitis. Infect Immun 2009, 77: 1031-1043.